The World Health Organization (WHO) and the governments of most countries have changed the Covid-19 policy based on advices of a low-ranking American company.
According to a report published in the ‘The Guardian’; the world-renowned health journal Lancet and the New England Journal of Medicine Hydroxychloroquine Studies have obtained data from an American organization called Sargisof, an organization that specializes in science fiction and adult content writing.
The Guardian reports that the World Health Organization and the governments of a number of countries have changed their policies to include faulty information from a low-quality US healthcare provider. However, the study published in two well-known medical journals has been questioned as it has been published with information from this institution.
An investigation by the Guardian found that employees of the American Sargisof’s company primarily create content for science fiction. The company has so far been unable to provide any explanation for the data provided by Covid-19.
Based on the data provided by the company, thousands of hospitals in Latin American countries have changed their Covid-19 policy and the data was also behind the closure of trials of hydroxychloroquine by the World Health Organization and other research institutes around the world.
The investigation further found that none of the employees of Sargiysof Company had any experience in data acquisition and scientific matters. There is a worker who is a writer of science fiction and a fantasy painter. There is another employee who works as a marketing executive and models adult content and conducts various events.
The company's LinkedIn page has only 100 followers and 6 employees which come down to three on Wednesday.
Although Sargiysof claims they have the ability to collect the fastest data from the highest number of hospitals in the world. However, their online presence is very low in reality. They have only 160 followers on Twitter and there are no activities from October 2017 to March 2020.
There is also a mystery about the identity of the company's chief executive director Sapan Desai.